
Novartis Buys Excellergy for $2B, Anthropic Vs. Pentagon, The Mansion Section | Diet TBPN
TBPN
00:00
Accelergy’s biotech playbook pays off
John Coogan explains how stealth biotech startup Accelergy sold to Novartis for $2 billion and why the outcome fits a classic drug-company venture model.
Play episode from 00:00
Transcript


